WP7

Cellular/molecular pharmacology. In vivo evaluation of the monomer-monomer interface inhibitors against enzymes biolibrary and wt and resistant ovarian carcinoma cell line.

1. Enzyme bio-library preparation, enzyme purification.

2. Compounds library rapid screening assay.

3. Examination of cytotoxic effects of compounds designed to limit the intracellular levels of TS protein in cDDP-sensitive and cDDP-resistant cell lines and in a non-carcinoma cell line.

4. Evaluation of cell growth effects of TS monomer-monomer interface inhibitors in combination with cisplatin.

5. Characterization of the intracellular molecular mechanisms involved in the action of inhibitors.

6. Evaluation of transcription levels of the folate dependent enzymes in ovarian human cell lines (ATCC).

7. Identification of molecules competing with TS for their binding to mRNA.


-------------------------------------------------------------------------------------
WP SCHEME



info@lights-eu.org
MANAGEMENT
Coordination
Committee
Guest scientists
Participants
OBJECTIVE
Synopsis
Project summary
PARTNERS
WORK PACKAGES
Overview
PROJECT MEETINGS
 
LIGands to interfere with Human TS - LIGHTS is a STREP project within the 6FP. Lights is focused on ovarian cancer and carried
out by a consortium of six partners: University of Modena and Reggio Emilia (I) - University di Paris Sud (FR)
European Media Laboratories (D) - Molecular Discovery (I) - Naxospharma (I) - University of California San Francisco (UCSF)

 
Realized by Newlogic